Search research articles
Contact Us
Filters
Showing results (21-30 of 284) with videos related to
Page
of 29
Sort By:
International Journal of Cancer
|
January 3, 2013
Caveolin-1 is a novel regulator of K-RAS-dependent migration in colon carcinogenesis
Upal K Basu Roy, Rebecca S Henkhaus, Fotios Loupakis, et al.
Cancer Treatment Reviews
|
November 28, 2021
Triplet chemotherapy in combination with anti-EGFR agents for the treatment of metastatic colorectal cancer: Current evidence, advances, and future perspectives
Gunnar Folprecht, Erika Martinelli, Thibault Mazard, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 22, 2015
Early tumour shrinkage as a prognostic factor and surrogate end-point in colorectal cancer: a systematic review and pooled-analysis
Fausto Petrelli, Filippo Pietrantonio, Chiara Cremolini, et al.
Investigational New Drugs
|
June 3, 2019
Pharmacological effects of the simultaneous and sequential combinations of trifluridine/tipiracil (TAS-102) and 5-fluorouracil in fluoropyrimidine-sensitive colon cancer cells
Paola Orlandi, Daniela Gentile, Marta Banchi, et al.
The Oncologist
|
December 1, 2023
A Misleading Case of NTRK-Rearranged Papillary Thyroid Carcinoma
Marco Maria Germani, Chiara Boccaccio, Antonio Matrone, et al.
British Journal of Clinical Pharmacology
|
April 19, 2022
Plasma levels of VEGF-A and VCAM-1 as predictors of drug-induced hypertension in patients treated with VEGF pathway inhibitors
Julia C F Quintanilha, Kelli Hammond, Yingmiao Liu, et al.
The Oncologist
|
May 8, 2026
Survival benefit of oral systemic monotherapy in previously treated metastatic colorectal cancer: a meta-analysis
Per Pfeiffer, Chiara Cremolini, Michel Ducreux, et al.
Expert Review of Anticancer Therapy
|
October 29, 2015
TAS-102 for the treatment of metastatic colorectal cancer
Lisa Salvatore, Daniele Rossini, Roberto Moretto, et al.
Expert Review of Clinical Pharmacology
|
May 6, 2016
Ramucirumab for the treatment of gastric cancers, colorectal adenocarcinomas, and other gastrointestinal malignancies
Giuseppe Aprile, Laura Ferrari, Chiara Cremolini, et al.
The Oncologist
|
December 1, 2025
Neoadjuvant immunotherapy for dMMR/MSI-H locally advanced rectal cancer patients: demystifying the 100% clinical complete response paradigm
Federica Marmorino, Federica Morano, Maria Anna Canciello, et al.
Page
of 29
Search research articles
Search
Showing results (21-30 of 284) with videos related to
Sort By:
Page
of 29
International Journal of Cancer
|
January 3, 2013
Caveolin-1 is a novel regulator of K-RAS-dependent migration in colon carcinogenesis
Upal K Basu Roy, Rebecca S Henkhaus, Fotios Loupakis, et al.
Cancer Treatment Reviews
|
November 28, 2021
Triplet chemotherapy in combination with anti-EGFR agents for the treatment of metastatic colorectal cancer: Current evidence, advances, and future perspectives
Gunnar Folprecht, Erika Martinelli, Thibault Mazard, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 22, 2015
Early tumour shrinkage as a prognostic factor and surrogate end-point in colorectal cancer: a systematic review and pooled-analysis
Fausto Petrelli, Filippo Pietrantonio, Chiara Cremolini, et al.
Investigational New Drugs
|
June 3, 2019
Pharmacological effects of the simultaneous and sequential combinations of trifluridine/tipiracil (TAS-102) and 5-fluorouracil in fluoropyrimidine-sensitive colon cancer cells
Paola Orlandi, Daniela Gentile, Marta Banchi, et al.
The Oncologist
|
December 1, 2023
A Misleading Case of NTRK-Rearranged Papillary Thyroid Carcinoma
Marco Maria Germani, Chiara Boccaccio, Antonio Matrone, et al.
British Journal of Clinical Pharmacology
|
April 19, 2022
Plasma levels of VEGF-A and VCAM-1 as predictors of drug-induced hypertension in patients treated with VEGF pathway inhibitors
Julia C F Quintanilha, Kelli Hammond, Yingmiao Liu, et al.
The Oncologist
|
May 8, 2026
Survival benefit of oral systemic monotherapy in previously treated metastatic colorectal cancer: a meta-analysis
Per Pfeiffer, Chiara Cremolini, Michel Ducreux, et al.
Expert Review of Anticancer Therapy
|
October 29, 2015
TAS-102 for the treatment of metastatic colorectal cancer
Lisa Salvatore, Daniele Rossini, Roberto Moretto, et al.
Expert Review of Clinical Pharmacology
|
May 6, 2016
Ramucirumab for the treatment of gastric cancers, colorectal adenocarcinomas, and other gastrointestinal malignancies
Giuseppe Aprile, Laura Ferrari, Chiara Cremolini, et al.
The Oncologist
|
December 1, 2025
Neoadjuvant immunotherapy for dMMR/MSI-H locally advanced rectal cancer patients: demystifying the 100% clinical complete response paradigm
Federica Marmorino, Federica Morano, Maria Anna Canciello, et al.
Page
of 29